The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The Kineret Market Progress Through 2030?
The growth observed during the historic period was primarily due to several factors: unaddressed needs in inflammatory disorders, the clinical effectiveness of il 1 blockade, enhanced diagnosis of rare syndromes, the widespread adoption of biologics by hospitals, and the availability of long-term safety data.
The expected growth over the forecast period is due to a heightened awareness of autoinflammatory diseases, the extension into new indications, increased usage of biologics in pediatric populations, enhanced access to specialized medical care, and continuous innovation in biologic treatments.
Prominent trends during the projection period involve the expanded application of IL-1 inhibitors, an increase in the treatment of autoinflammatory diseases, advancement in pediatric inflammatory care, a growing preference for targeted cytokine therapies, and a greater deployment in rare inflammatory syndromes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20129&type=smp
Which Major Factors Are Contributing To The Development Of The Kineret Market?
The growing incidence of autoimmune diseases is expected to drive the expansion of the kineret market in the coming years. Autoimmune diseases encompass a range of conditions in which the immune system mistakenly attacks the body’s own cells, tissues, and organs, perceiving them as harmful. This rising prevalence is influenced by a mix of genetic predisposition, environmental exposures, and lifestyle-related factors. Kineret is a therapeutic treatment used to manage autoimmune disorders, particularly those associated with excessive inflammation caused by immune system dysfunction. For instance, in May 2023, the National Institute for Health and Care Research (NIHR), a UK-based health and care research organization, reported that autoimmune disorders affect approximately one in ten individuals. The study, based on 22 million people, found that around 10% of the population is impacted, including 13% of women and 7% of men. As a result, the increasing burden of autoimmune diseases is fueling the growth of the kineret market.
Kineret Market Driver: Growing Burden Of Inflammatory Diseases Supporting Market Expansion
The rising prevalence of inflammatory diseases is also expected to significantly boost the kineret market. These diseases are characterized by abnormal immune responses that lead to persistent or acute inflammation in various tissues and organs. Key contributing factors include an aging population, higher exposure to environmental pollutants, and lifestyle patterns such as unhealthy diets, physical inactivity, and smoking. Kineret (anakinra) plays a crucial role in managing such conditions by inhibiting interleukin-1 (IL-1), a protein that drives inflammatory responses. For example, in 2023, Crohn’s and Colitis Canada, a Canada-based nonprofit organization, highlighted a rapid increase in inflammatory bowel disease (IBD) cases. The number of affected individuals is projected to rise from 322,600 (0.8% of the population) in 2023 to 470,000 (1.1%) by 2035. Additionally, annual diagnoses are expected to grow from 11,000 cases (one every 48 minutes) in 2023 to 14,000 cases (one every 38 minutes) by 2035. Consequently, the increasing prevalence of inflammatory diseases is a key factor driving the growth of the kineret market.
What Key Segment Areas Are Included In The Kineret Market Assessment?
The kineret market covered in this report is segmented –
1) By Indication: Treatment Of Rheumatoid Arthritis, Treatment Of Still’s Disease, Treatment Of Cryopyrin-Associated Periodic Syndromes, Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMIDN)
2) By Formulation: Injectable formulation, Pre-filled Syringes Or Auto-injectors
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesalers And Distributors
5) By End-User: Hospitals, Specialty Clinics, Outpatient Treatment Centers, Home Healthcare Providers
Which Trends Are Influencing The Expansion Of The Kineret Market?
A significant trend in the Kineret market is the embrace of strategic alliances to develop innovative Kineret-based products and secure a competitive advantage. These collaborations enable companies operating in the Kineret market to merge resources and expertise, bolster research and development initiatives, expand their market footprint, and expedite product commercialization, thereby fostering innovation and growth within the industry. For instance, in May 2024, Swedish Orphan Biovitrum AB, a biopharmaceutical company from Sweden, collaborated with Handok Inc., a pharmaceutical company located in South Korea, to launch Kineret (anakinra) in South Korea. This partnership unites Handok’s local insights with Sobi’s global biopharmaceutical capabilities, particularly regarding rare diseases.
Who Are The Major Companies Operating In The Kineret Market?
Major companies operating in the kineret market are Sobi (Swedish Orphan Biovitrum AB)
Access The Complete Kineret Market Report:
https://www.thebusinessresearchcompany.com/report/kineret-global-market-report
What Is The Largest Regional Market In The Kineret Market?
North America was the largest region in the kineret market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kineret market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model